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 ADHD stimulant misuse is defined as taking a stimulant used to treat ADHD either 
without having a prescription for that stimulant or in a manner that deviates from the 
prescription’s instructions. This has been a growing trend among undergraduate students over 
recent years. Prior research has found that misusers are likely to have severe symptoms of 
ADHD, misuse for primarily academic reasons, and display problems associated with substance 
abuse. The current study aimed to determine the predictive value of ADHD symptomatology on 
frequency of ADHD stimulant misuse, mediated by academic motives for misuse and substance 
abuse problems. The survey for this study was completed by 1,082 students at a state university 
in southeastern Virginia. Data from 184 misusers were analyzed using SEM path analysis. A 
significant direct effect was found with ADHD symptomatology on frequency of misuse, and 
this effect was mediated by academic motives for misuse, but not by substance abuse problems. 
The results suggest that undergraduate students with undiagnosed problems with attention and 
hyperactivity might have academic difficulties for which they would turn to ADHD stimulant 
misuse as a solution. While not analyzed in this study, such a student, who may already be using 
other substances for non-academic reasons, could later develop medical, social, and family 






































































































 I would like to thank my advisor, Dr. Valerian Derlega, as well as Dr. J.D. Ball for all the 
feedback and guidance they have provided since the very beginning of this study. I would also 
like to thank Dr. Debra Major for her time and insight towards this study. Finally, I would like to 
thank Peggy Kinard for her assistance with distributing the survey as well as Dr. Abby Braitman, 



















TABLE OF CONTENTS 
  Page 
LIST OF TABLES………………………………………………………………………………..vi 
LIST OF FIGURES……………………………………………………………………………...vii 
Chapter 
I. INTRODUCTION………………………………………………………………………………1 
II. CHARACTERISTICS OF ADHD STIMULANT MISUSE…………………………………..3 







 INTERNAL CONSISTENCY.…………………………………………………………..14 
 NON-MISUSER CHARACTERISTICS………………………………………………...14 
 MISUSER CHARACTERISTICS……………………………………………………….15 






 A. MISUSER QUESTIONS……………………………………………………………..33 
 B. NON-MISUSER QUESTIONS………………………………………………………35 
 C. ADULT ADHD SELF-REPORT SCALE……………………………………………36 
 D. WENDER-UTAH RATING SCALE……………………………...…………………38 
 E. CAFFEINE MOTIVES QUESTIONNAIRE, COGNITIVE ENHANCEMENT…….42 
 F. DRUG ABUSE SCREENING TEST, 10-ITEM VERSION…………………………44 
 G. UNIVERSITY ANNOUNCEMENT WEBPAGE……………………………………45 
 H. CONSENT FORM……………………………………………………………………46 





LIST OF TABLES 
Table                Page 
1.  Non-Misuser Characteristics……………………………………………………………..15 
2. Misuser Characteristics…………………………………………………………………..16 
3. Mean, SDs, and Correlations between Predictor, Outcome, and Demographic  
Variables............................................................................................................................17 
 
4. Factor Loadings onto ADHD Symptomatology Latent Variable………………………..18 
5. Direct and Indirect Effects for the Full Model…………………………………………...19 


















LIST OF FIGURES 
Figure                Page 
1.  Predicted model for direct and indirect effects of ADHD symptom severity on frequency  
of ADHD stimulant misuse………………………………………………………………..2 
 
2. Standardized path coefficients for full model……………………………………………19 




















 Prescription stimulant medications, such as Ritalin, Adderall, Focalin, Vyvanse, and 
Concerta, are typically used to treat attention-deficit/hyperactivity disorder (ADHD; Lakhan & 
Kirchgessner, 2012). Recently, however, studies report that undergraduate students nationwide 
have sometimes used these medications either without a physician prescription or in a manner 
that deviates from prescription instructions, constituting ADHD stimulant misuse (Teter, 
McCabe, Cranford, & Boyd, 2005).  
Previous work has suggested that ADHD stimulant misuse may represent self-treatment 
for undiagnosed ADHD. Peterkin, Crone, Sheridan, and Wise (2011) surveyed 184 students at a 
large university in Northern Virginia. The students responded to questions regarding ADHD 
symptomatology as measured by the World Health Organization (WHO) Adult ADHD Self-
Report Scale (ASRS), ADHD stimulant misuse, motives for misuse, and perceived impact on 
grades. Misusers were identified as students who reported taking ADHD medications that had 
not been prescribed to them. The researchers found that misusers were seven times more likely to 
report severe symptoms of ADHD compared to non-misusers. Additionally, they found that 87% 
of misusers cited academic reasons for misuse and 76% indicated that the misuse was improving 
their grades (Peterkin et al., 2011). The authors argued for the need to better understand the role 
ADHD symptomatology plays in characteristics and outcomes of ADHD stimulant misuse 
among undergraduates. 
The current study further investigated the notion that ADHD stimulant misuse may be 
explained by self-treatment for undiagnosed ADHD using self-reported ADHD symptomatology 
to predict the frequency of ADHD stimulant misuse through the mediating mechanisms of 
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academic motives of misuse and substance abuse problems. The proposed model for this study 
















Figure 1. Predicted model for direct and indirect effects of ADHD symptom severity on 
























CHARACTERISTICS OF ADHD STIMULANT MISUSE 
 ADHD is a neurodevelopmental disorder characterized by problems with inattention, 
hyperactivity, distractibility, and impulsivity interfering with daily functioning (Matte et al., 
2015). These problems are particularly detrimental in a workplace or school setting, especially 
among those who are untreated (Fried et al., 2012). While this disorder is typically perceived to 
be a childhood problem and its diagnosis requires childhood onset, approximately half of those 
diagnosed continue to display symptoms through adulthood (Lakhan & Kirchgessner, 2012). 
Though prevalence rates for ADHD are difficult to interpret due to the nature of sampling and 
variability in its diagnosis (Cuffe, Moore, & McKeown, 2005), current national estimates suggest 
an adult ADHD prevalence rate of 3-5% (Faraone & Bierderman, 2005; Matte et al., 2015). 
 Precise rates of undergraduate ADHD stimulant misuse are also hard to obtain. Reports 
have documented undergraduate misuse prevalence rates ranging from 8% (Teter et al., 2005) to 
48% (Ilieva & Farah, 2015). There are no definitive explanations for these variations, but they 
are likely to be due to variability in sampling and how separate researchers identify misusers. 
Despite this, it is clear that ADHD stimulant misuse is a significant occurrence within the 
undergraduate population. Among undergraduate stimulant misusers, students have reported an 
average of 6-9 incidents of stimulant misuse during the span of their undergraduate studies 
(Ilieva & Farah, 2015). 
 A particular characteristic of interest for the current study is the role that ADHD 
symptoms play in motivating misuse. Because the stimulants taken by misusers are traditionally 
used to treat ADHD, it seems likely that some relationship exists between the decision to misuse 
and the experience of ADHD symptoms. In fact, several studies have documented that misusers 
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are more likely to report more severe ADHD symptoms than non-misusers (Hartung et al., 2013; 
Ilieva & Farah, 2015; Peterkin et al., 2011; Rabiner, Anastopoulos, Costello, Hoyle, & 
Swartzwelder, 2010). Additionally, Rabiner and colleagues (2010) found that self-reported 
attention difficulties significantly predicted incidents of new onset misuse among college 
students over a five week period. However, the relationship between ADHD symptoms and 
medication misuse is made more difficult to investigate by problems associated with self-report 
data. For example, misusers may self-perceive ADHD symptoms when no attention problems are 
actually present. In a study conducted by Ilieva and Farah (2015), self-reported attention 
problems and objectively measured attention problems were compared between misusers and 
non-misusers. While misusers had significantly higher self-reported attention problems 
compared to non-misusers, misusers did not show significantly different problems with omission 
errors, reaction time, or commission errors on an objective attention and impulsivity test 
compared to non-misusers. 
Collectively, prior research literature highlights a fundamental limitation in the accuracy 
of self-report determined ADHD diagnoses and symptomatology. A proper clinical diagnosis of 
ADHD requires a combination of self-reported symptoms, peer- or family-reported symptoms, 
family history, neurological testing, clinical assessment, and diagnostic judgment from a licensed 
health care provider with the skills to make this assessment (Barkley, 2014). So while previous 
research has found that self-reported attention problems may be related to ADHD stimulant 
misuse, self-report alone is insufficient to diagnose ADHD. This is, in fact, a limitation of the 
current study as well. However, the current study improves upon this self-report process by 
inquiring about a childhood and family history of these symptoms. This study acknowledges the 
diagnostic limitation and does not purport to show a causal mechanism between ADHD and 
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characteristics of misuse, but limits this investigation to a preliminary assessment of the 
predictive value of self-reported attention problems for the decision to misuse stimulant drugs. In 
this study, personal and family history, current ADHD symptomatology, and past ADHD 
symptomatology, which are all components of a clinical assessment of ADHD, will serve as 
formative indicators for the latent variable called “ADHD symptomatology” (Figure 1). This 
latent variable is meant to theoretically represent a preliminary assessment of ADHD symptoms 
whereby scores on the formative indicators (personal and family history, current ADHD 
symptomatology, past ADHD symptomatology) are the root cause for a participant’s outcomes 
on the latent variables (ADHD symptomatology; Bollen & Diamantopoulos, 2015). 
 Another variable and uncertain characteristic of ADHD stimulant misuse is how it affects 
academic performance. Studies have shown that students who misuse ADHD stimulants tend to 
have lower GPA and poorer study habits compared to non-misusers (Ilieva & Farah, 2015; 
Rabiner et al., 2010). However, the majority of misusers report a belief that their misuse of 
ADHD stimulants improves their grades (Peterkin et al., 2011). While it is likely that these 
variables are measuring different constructs, the results of these studies bring into question the 
exact academic benefit of misuse. On the other hand, proper use of stimulants for persons with 
ADHD is very strongly associated with an improved prognosis, with as much as 80% treatment 
efficacy (Barkley, 2014). Additionally, there has been research suggesting some cognitive 
benefit to stimulant medications even when someone does not have a diagnosis of ADHD 
(Lakhan & Kirchgessner, 2012). If ADHD stimulant misuse represents self-treatment for 
undiagnosed ADHD, then misusers may actually be deriving a cognitive benefit from misuse that 
improves their academic performance. 
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 Understanding the nature of any academic benefits of misuse is particularly important for 
research because perceived academic benefit may be the major reason for misuse in the first 
place. A large body of evidence shows that misusers report academic reasons as their primary 
basis for misuse (Hartung et al., 2013; Peterkin et al., 2011; Rabiner et al., 2009; Teter et al., 
2005). Typically, these include “help concentrate,” “study for an exam,” or “improve grades.” 
Other common motives for misuse include social reasons, such as “socialize better” and “get 
energized,” and personal enhancement reasons, such as “get high” and “lose weight” (Hartung et 
al., 2013; Peterkin et al., 2011; Rabiner et al., 2009; Teter et al., 2005). However, these 
alternative motives have all been reported significantly less often than academic enhancement 
reasons. Thus, there is a clear need to better understand how students perceive these stimulant 
medications to be affecting them. 
 Substance abuse is also often assumed and studied in the context of ADHD stimulant 
misuse, since prescription stimulants are considered Schedule II regulated drugs under the 
Controlled Substances Act (CSA; Lakhan & Kirchgessner, 2012). Many studies have found that 
misusers are more likely than non-misusers to experience problems with general substance abuse 
(Hartung et al., 2013; Rabiner et al., 2010; Sepúlveda et al., 2011; Teter et al., 2005). 
Additionally, a study conducted on those who distribute ADHD medications to misusers found 
that distributors are also more likely to experience substance abuse problems compared to non-
distributors (DeSantis, Anthony, & Cohen, 2013). Rabiner et al. (2010) also found that substance 
abuse was a significant predictor of new incidents of ADHD stimulant misuse. Thus, substance 
abuse, as well as problems typically associated with it, may mediate the predictive value of 





THE CURRENT STUDY 
While many studies have been conducted that describe the characteristics of misusers, 
few have attempted to predict the frequency of ADHD stimulant misuse using these 
characteristics. The purpose of the current study is to identify the predictive value ADHD 
symptomatology has on several characteristics of ADHD stimulant misuse. This will be assessed 
using an online survey incorporating several validated measures. We hypothesize that as ADHD 
symptomatology increases, the frequency of ADHD stimulant misuse will also increase. This 
relationship will occur both directly and indirectly through academic motives of misuse and 
substance abuse problems mediators (Figure 1).  
We propose that an undergraduate student suffering from unexplained problems with 
inattention and impulsivity would desire to find an easy solution for overcoming these problems. 
ADHD stimulant misuse may be perceived as one such simple solution. Additionally, students 
experiencing these problems will likely encounter academic difficulties as well. This would 
likely motivate them to address these problems and find a solution to improve their academic 
performance. ADHD stimulant misuse could be viewed as a solution to these academic 
difficulties. Finally, a student with undiagnosed ADHD symptoms may already be impulsively 
turning to substance abuse and be experiencing consequences associated with substance abuse. 
This may explain why such a student would turn to an illegal behavior as a solution to their 









 A total of 1,082 students from a large university in southeastern Virginia completed the 
survey. Among these participants, 206 (19.04%) indicated that they had misused ADHD 
stimulants over the past six months. Twenty-two misusers were removed from analysis because 
they either were not undergraduate students, did not complete the survey as instructed, or had 
outliers, leaving 184 misusers for the final analyses. The mean age of the misusers was 22.31 
years (SD = 5.55). The majority of misusers was female (65.80%), Caucasian (62.50%), and in 
their senior year of undergraduate studies (31.00%). 
MEASURES 
 ADHD stimulant misuse. One question separated participants into two groups. 
Answering “Yes” to the question “During the past 6 months, have you ever taken an ADHD 
stimulant medication (ex: Ritalin, Adderall, Concerta, Focalin, Vyvanse) without having a 
prescription for that medication or in a manner not recommended by the prescription's 
instructions (ex: taking more pills than suggested, taking pills at times not suggested)?” placed 
participants into the “Misuser” group. Answering “No” to this question placed participants into 
the “Non-Misuser” group. 
 Participants in the misuser group were asked seven questions regarding characteristics of 
their misuse (Appendix A). These included the name and dosage of their most often used 
stimulant, whether or not they were currently prescribed the stimulant, the frequency of misuse 
over the past six months, how they perceived the misuse had affected their grades, and the time 
of the day and day of the week they most often misuse stimulants. The dosage question also 
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served as an attention check as participants must write “Don’t know” if they did not know the 
dosage of their most often used stimulant. 
 Non-misuser participants were asked four questions regarding their knowledge of ADHD 
stimulant misuse (Appendix B). These included their awareness of misuse and whether they 
personally knew anyone who has misused or has distributed stimulant medications to other 
students. Additionally, non-misusers were asked to list any drug, medication, or substance they 
had used in the past six months for the purpose of academic improvement. This question was 
designed to catch any false negatives who may not have realized they were engaging in ADHD 
stimulant misuse. Additionally, this question served as an attention check as participants must 
write “N/A” if they have not used any substances for academic improvement in the past six 
months. 
 ADHD symptomatology. Three sets of questions were asked to determine the severity of 
ADHD symptomatology among participants. 
 Personal and family history. Four questions were asked regarding current and past 
diagnoses of ADHD, as well as a family history of ADHD. These included if the participant was 
ever diagnosed with ADHD by a healthcare professional, if the participant was currently 
diagnosed with ADHD, and whether their biological parents and siblings were ever diagnosed 
with ADHD. These were all yes or no questions. 
 Current symptomatology. The six screening questions from the WHO ASRS were used 
to assess current ADHD symptom severity (Appendix C). These six questions had the highest 
sensitivity (68.7%) and specificity (99.5%) of all the questions in the ASRS (Kessler et al., 
2007). An example question from this scale was “How often do you have problems remembering 
appointments or obligations?” These questions were measured on a 5-point Likert scale ranging 
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from 1 (Never) to 5 (Very Often). The Cronbach’s alpha for this scale was .63-.72. This was 
expected to be low because the methods used to develop the scale intentionally selected the least 
number of questions possible to capture the symptoms on two different dimensions: inattention 
and hyperactivity (Kessler et al., 2007). Test-retest reliability was found to be between .58-.77. 
Predictive validity, measured as the screener’s ability to predict new cases of adult ADHD 
diagnosed by clinicians who did not use the scale, was .82 (Kessler et al., 2007). 
 Past symptomatology. Twenty-five questions from the Wender Utah Rating Scale 
(WURS) were used to measure past ADHD symptom severity (Appendix D). This was important 
to measure because proper clinical assessment of ADHD in adults is significantly improved by 
investigating symptoms retrospectively (Ward, Wender, & Reimherr, 1993). An example 
question from this scale was “As a child, I was (or had): concentration problems, easily 
distracted.” These questions were measured on a 5-point Likert scale ranging from 1 (Not at all) 
to 5 (Very much). Cronbach’s alpha for this measure was .78-.91. Split-half reliability was found 
to be .9. Convergent validity, as measured by correlating the scores from the WURS to scores 
from the Conners Abbreviated Rating Scale, a short measure of childhood ADHD symptoms, 
was .41-.49 (Ward et al., 1993). 
 Academic motives of misuse. The six cognitive enhancement questions from the 
Caffeine Motives Questionnaire (CMQ-CE) were used to assess academic motives for ADHD 
stimulant misuse (Appendix E; Irons et al., 2014). This questionnaire was selected because the 
motives represented by these questions were analogous to the academic motives assessed in 
previous ADHD stimulant misuse research (Hartung et al., 2013; Peterkin et al., 2011; Rabiner et 
al., 2009; Teter et al., 2005). An example motive from the CMQ-CE was “to feel more alert.” 
These questions were measured on a 5-point Likert scale ranging from 1 (Never) to 5 (Almost 
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always). Cronbach’s alpha for the CMQ-CE was .92. Construct validity, measured as the 
correlation between CMQ-CE and frequency of caffeine consumption, was .2-.25. Discriminant 
validity, measured as the correlation between CMQ-CE and the three other motives used in the 
full CMQ (negative affect relief, reinforcing effects, and weight control), was .26-.58 (Irons et 
al., 2014). 
 Substance abuse problems. The Drug Abuse Screening Test, 10-item version (DAST-
10) was used to assess problems with general substance abuse, excluding the use of ADHD 
stimulants (Appendix F). This was a short measure that has been shown to accurately capture 
substance abuse problems in diverse populations, including patients with ADHD (Yudko, 
Lozhkina, & Fouts, 2007). An example question from the DAST-10 was “Have you used drugs 
other than those required for medical reasons?” All of these were yes or no questions. The 
Cronbach’s alpha for the DAST-10 was .86-.94. Concurrent validity, measured as the correlation 
between the DAST-10 and the longer DAST-20, was .97. Construct validity, measured as the 
correlation between the DAST-10 and the Addiction Severity Index, was .31-.4 (Yudko et al., 
2007). 
Demographics. Four demographic questions were included regarding the participants’ 
age, gender, year in school, and race. 
PROCEDURE 
 The online survey was developed using Qualtrics. After obtaining approval from the 
ODU IRB, an announcement webpage was created that included the link to the survey 
(Appendix G). This webpage was posted on the university’s announcements website and a link 
to the webpage was incorporated into the university’s student announcements email. This email 
was sent to all students every day around 12:20 am. A statement was included on the webpage 
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asking undergraduate students to participate in a study investigating college ADHD stimulant 
use. The webpage was posted for several weeks of the Fall 2016 semester. For the remaining few 
weeks of the Fall 2016 semester, participants were recruited through the university’s psychology 
research participation system. 
 Before beginning the survey, participants read a consent form asking if they consented to 
participate in the study (Appendix H). To maintain anonymity, online signatures were not 
obtained. After consenting and completing the survey, participants were debriefed, provided with 
substance abuse and ADHD resources, and encouraged to leave any comments regarding the 
study (Appendix I). Upon completion of the survey, participants recruited through the 
announcements webpage were redirected to a separate survey where they could enter into a raffle 
to win a $50 Amazon gift card. This raffle was run by a third party unaffiliated with the current 
study. Information collected by this third party were never shared with the researcher. 
Participants recruited through the research participation system were granted 0.5 psychology 
research credits upon completion of the survey. 
ANALYSIS 
 The strength of the predictions within the proposed model was assessed using structural 
equation modeling (SEM). For each scale, a total score was produced by adding the assigned 
point values for each of the selected responses together. Total score on the DAST-10 was the 
operationalization for substance abuse problems. The total score for the CMQ-CE was used to 
represent academic motives for misuse. For the ADHD symptomatology latent variable, the total 
scores on the WHO ASRS, WURS, and personal and family history questions were loaded as 
formative indicators. Models that either had perfect fit or a non-significant χ2, root mean square 
error of approximation (RMSEA) of < .1, comparative fit index (CFI) > .90, and standardized 
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root mean square residual (SRMR) < .05 were considered to have adequate fit (Hooper, 
Coughlan, & Mullen, 2008). 
 Power analysis and sample size determination for SEM are difficult to apply. Currently, 
there are three generally accepted power analysis methods, and each one typically gives a 
different minimum sample size using similar variables as the others (MacCallum, Browne, & 
Sugawara, 1996; Muthén & Muthén, 2002; Satorra & Saris, 1985). Additionally, researchers 
using SEM have been known to cite general rules-of-thumb as their estimate of sample size 
(Wolf, Harrington, Clark, & Miller, 2013). A study by Wolf and colleagues (2013) assessed the 
utility of each of these approaches. They not only found that each method produced a different 
minimum sample size needed to meet desired power, but also that the results fluctuated with 
varying characteristics of the models, such as bias and missing data. As such, the authors 
concluded that power analysis or rules-of-thumb alone are not enough to determine desired 
sample size for a study using SEM. They instead suggested determining sample size by 
accounting for the unique characteristics of the model and the study’s design in addition to a 
valid sample size estimation technique (Wolf et al., 2013). 
 Following these suggestions by Wolf et al. (2013), the current study sought a minimum 
misuser sample size with desired power at .8 and alpha at .05, and found the minimum sample 
size to be 90. This agrees with estimates for models using latent variables (Muthén & Muthén, 
2002; Wolf et al., 2013), as well as an accepted SEM rule-of-thumb ratio of 20 participants per 
variable (Tanaka, 1987). Additionally, this is a close estimate to the percentage of misusers 








 Cronbach’s alpha was used to determine the internal consistency of the scales used. The 
WURS (α = .944), CMQ-CE (α = .854), and the personal and family history measure (α = .713) 
all displayed good internal consistency. The ASRS (α = .603) had relatively low internal 
consistency. However, this was not considered problematic as this level of Cronbach’s alpha was 
expected to occur for this scale and is in agreement with results from its validation study (Kessler 
et al., 2007). The DAST-10 (α = .644) was also found to have relatively low internal consistency. 
This was considered problematic, and the implications of this are described in the Discussion. 
NON-MISUSER CHARACTERISTICS 
 The majority of non-misusers in this sample were aware that ADHD stimulant misuse 
was occurring (76.70%; Table 1). Most non-misusers also personally knew someone who had 
misused ADHD stimulants in the past (52.50%). Most non-misusers did not personally know 
someone who had distributed ADHD stimulants though (59.60%). Finally, six students (0.74%) 
indicated they were using ADHD stimulants for the purposes of academic improvement despite 
indicating that they were not a misuser and did not currently have a prescription for stimulant 
medication. It is possible that these false negatives did not consider what they were doing as 








Non-Misuser Characteristics           
Characteristic        Frequency (%)   
Know ADHD Stimulant Misuse 
 Yes        621 (76.70) 
 No        186 (23.00) 
 Missing       3 (0.40) 
Know Misuser 
 Yes        425 (52.50) 
 No        331 (40.90) 
 Missing       54 (6.70) 
Know Distributor 
 Yes        280 (34.60) 
 No        483 (59.60) 
 Missing       47 (5.80)    




 Misusers were described in this study as someone who either obtained and used a 
stimulant without having a prescription for it or someone who used their currently prescribed 
stimulant in a manner that deviates from the prescription’s instructions (e.g. taking more pills 
than suggested, taking pills at times not suggested). The majority of misusers in this sample 
belonged to the former category (72.30%; Table 2). The most commonly misused stimulant was 
Adderall (68.50%). The mean number of incidents of misuse over the past six months was 3.56 
(SD = 2.55). On average, misusers indicated that their misuse was only slightly improving their 
grades (M = 3.55, SD = 0.78). Most misusers were taking the stimulants on Mondays (25.00%) 
and in the morning (41.30%). According to the Physicians’ Desk Reference (PDR, 2017), most 
misusers seemed to take an appropriate dosage of their indicated medication (85.05%). It should 
be noted, however, that decisions regarding appropriate dosage relate to symptom intensity, body 
weight, side effect tolerance, and actual effects of the medication and can only be made by a 
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licensed health care professional (PDR, 2017). Thus, we cannot be certain whether or not an 




Misuser Characteristics           
Characteristic        Frequency (%)   
Type of Misuse 
 Prescribed       51 (27.70) 
 Non-Prescribed      133 (72.30) 
Stimulant Misused 
 Ritalin        9 (5.30) 
 Adderall       126 (68.50) 
 Concerta       6 (3.30) 
 Focalin       1 (0.50) 
 Vyvanse       27 (14.70) 
 Intuniv *       1 (0.55) 
 Methylphenidate*      1 (0.55) 
 Missing       13 (7.10) 
Effect on Grades 
 Significantly decreased     3 (1.60) 
 Decreased       5 (2.70) 
 Neither decreased nor increased    74 (40.20) 
 Increased       73 (39.70) 
 Significantly increased     16 (8.70) 
 Missing       13 (7.10) 
Time of Day for Misuse 
 Morning       76 (41.30) 
 Afternoon       43 (23.40) 
 Evening       53 (28.80) 
 Missing       12 (6.50) 
Day of Week for Misuse 
 Monday       46 (25.00) 
 Tuesday       23 (12.50) 
 Wednesday       27 (14.70) 
 Thursday       18 (9.80) 
 Friday        24 (13.00) 
 Saturday       13 (7.10) 
 Sunday       13 (7.10) 
 Missing       20 (10.90)    





  For all SEM analysis, missing data was handled using maximum likelihood (ML) 
estimation (Messer & Natarajan, 2008). Bootstrapping was used to reduce the impact of non-
normality (Preacher & Hayes, 2004). All results were estimated using STDYX estimation. 
Means, standard deviations (SDs), and bivariate correlations for all predictor, outcome, and 
demographic variables can be found in Table 3. Because age was found to significantly correlate 




Mean, SDs, and Correlations between Predictor, Outcome, and Demographic Variables   
Variable       1      2        3        4        5        6        7        8        9        10        11 
1. ADHD symptomatology1      -    .19*  .19*    .21*   .45** .62** .99**  .15   -.01     -.01      .03 
2. Academic motives of misuse -      .18*    .19*  -.02    .11      .12*  -.10    .12      -.01     .04 
3. Substance abuse problems           -       .16    -.04    .11      .21**  .15   -.07      .02      .02 
4. Frequency of misuse           -     .25** .25** .20*    .21*  -.07     .08      .10 
5. Personal and family history                                          -      .25**  .40**  .22** -.13   -.09     .10 
6. Current symptomatology                                                        -       .58**  .14    -.04     .02     .04 
7. Past symptomatology                                                                        -       .13      .01     .01     .03 
8. Age                                                                                                              -       -.03    .41**  .10 
9. Gender                                                                                                                     -      .17*  -.02 
10. Year in school                                                                                                                 -      -.01 
11. Race                    -  
Mean       57.70  18.51  2.95  3.56  1.20  14.05  42.41   22.31  -       -         - 
SD       22.49   5.46   1.86  2.55  1.34   3.53   21.00   5.55    -       -         - 
Min        0        6         0        1       0       0         0         18       -       -         - 
Max       109     30        9       12      4      30      100       50      -       -         -  
Note. 1- Measured as a composite variable. * p < .05 ** p < .001 
 
A confirmatory factor analysis (CFA) was first run to determine the factor loadings (b*) 
of personal and family history, current symptomatology, and past symptomatology on the ADHD 
symptomatology latent variable. This model was found to have perfect fit. However, while past 
symptomatology was found to strongly load onto the latent variable, personal and family history 
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as well as current symptomatology did not strongly load onto the latent variable (Table 4). 
Therefore, ADHD symptomatology was not considered a latent variable for the remainder of the 
analysis. Instead, the total scores of the personal and family history questions, ASRS, and WURS 
were added together to form an aggregate construct, whereby a composite variable is created to 
represent the cumulative effects of each variable contributing to the construct (Edwards, 2001). 
 
Table 4 
Factor Loadings onto ADHD Symptomatology Latent Variable      
Index      b*  SE  p         95% CI  
Personal and family history   .42  .08  .001      [0.27, 0.57] 
Current symptomatology   .60  .08  .001      [0.44, 0.76] 
Past symptomatology    .97  .11  .001      [0.76, 1.19] 
 
 
To determine the strength of the proposed model when treating all variables as composite 
scores, a path analysis, bootstrapping with 10,000 replications, was run on the full model (Figure 
2). The full model was found to have perfect fit. All path coefficients (b*) can be seen in Table 5. 
There were significant direct effects between ADHD symptomatology and frequency of misuse 
(b* = .18, p = .050, R2 = .14), academic motives of misuse (b* = .19, p = .009, R2 = .05), and 
substance abuse problems (b* = .19, p = .015, R2 = .06). There was also a significant direct effect 
between academic motives of misuse and frequency of misuse (b* = .17, p = .032). However, 
there was not a significant direct effect between substance abuse problems and frequency of 
misuse (b* = .06, p = .623). Additionally, there was a marginally significant indirect effect 
between ADHD symptomatology and frequency of misuse via academic motives of misuse (b* = 


















Figure 2. Standardized path coefficients for full model. Significance is based off bootstrapped 
CI. * indicates that 95% CI does not include 0. Although not graphically represented, age was 





Direct and Indirect Effects for the Full Model        
Pathway      b*        SE            p   95% CI  
Direct effect between frequency of misuse and 
 ADHD symptomatology   .18        .01          .050         [0.01, 0.04] 
 Academic motives of misuse   .17        .03          .032         [0.01, 0.14] 
 Substance abuse problems   .06        .15          .623         [-0.22, 0.38] 
Direct effect between ADHD symptomatology and 
 Academic motives of misuse   .19        .02          .009         [0.01, 0.09] 
 Substance abuse problems   .19        .01          .015         [0.01, 0.03] 
Indirect effect via 
 Academic motives of misuse   .04        .02          .054        [-0.01, 0.09] 
 Substance abuse problems   .01        .02          .817        [-0.04, 0.05]  
















Because the DAST-10 displayed low internal consistency within this sample, the 
substance abuse problems variable was removed from the model and the path analysis, 
bootstrapping with 10,000 replications, was re-run (Figure 3). This model was also found to have 
perfect fit. Significant direct effects were again found between ADHD symptomatology and 
frequency of misuse (b* = .19, p = .037, R2 = .14) as well as between ADHD symptomatology 
and academic motives of misuse (b* = .19, p = .009, R2 = .06). There was also a significant direct 
effect between academic motives of misuse and frequency of misuse (b* = .18, p = .026). 
Finally, the indirect effect between ADHD symptomatology and frequency of misuse via 












Figure 3. Standardized path coefficients for model without substance abuse problems. 
Significance is based off bootstrapped CI. * indicates that 95% CI does not include 0. Although 

















Direct and Indirect Effects for the Model Without Substance Abuse Problems    
Pathway      b*        SE            p   95% CI  
Direct effect between frequency of misuse and 
 ADHD symptomatology   .19        .01          .037         [0.01, 0.04] 
 Academic motives of misuse   .18        .03          .026         [0.01, 0.14] 
Direct effect between ADHD symptomatology and 
 Academic motives of misuse   .19        .02          .009         [0.01, 0.09] 
Indirect effect via 
 Academic motives of misuse   .05        .02          .048         [0.01, 0.09]  
Note. Age was included as a significant covariate in this model. 
 
 
As an exploratory analysis, the model in Figure 2 was re-tested using only misusers who 
were not prescribed their most often misused stimulant (N = 133). This was run because it is 
theoretically possible that problems related to substance abuse are more likely to arise in non-
prescribed misusers, as their act of misuse more similar to constructs of substance abuse 
problems compared to prescribed misusers (Yudko et al., 2007). The path analysis was re-run, 
bootstrapping with 10,000 replications. This model was found to have perfect fit. However, the 
direct effect between substance abuse problems and frequency of misuse remained non-
significant (b* = .18, p = .16, R2 = .05). Additionally, the indirect effect of ADHD 
symptomatology and frequency of misuse via substance abuse problems also remained non-











 The purpose of this study was to determine the predictive value of ADHD 
symptomatology on the frequency and characteristics of ADHD stimulant misuse. Results from 
the path analyses revealed that ADHD symptomatology significantly predicted frequency of 
ADHD stimulant misuse. Based on these findings, an undergraduate student with higher ADHD 
symptom severity is at particular risk for misusing ADHD stimulants more often. This provides 
support to the notion that ADHD stimulant misuse may represent a form of self-treatment for 
undiagnosed or under-treated ADHD (Hartung et al., 2013; Peterkin et al., 2011; Rabiner et al., 
2009). Additionally, academic motives for misuse were also found to significantly predict 
frequency of ADHD stimulant misuse. Finally, a significant mediation effect of ADHD 
symptomatology on frequency of ADHD stimulant misuse via academic motives for misuse was 
found. Taking the whole model into account, the results seem to support the notion that a student 
experiencing unexplained problems such as difficulty concentrating on finishing assignments or 
staying awake or alert to study for a test would turn to stimulant misuse as a potential solution. 
To help determine whether this behavior might be seen by treatment providers as an adaptive or 
maladaptive self-assessment and self-treatment strategy, a follow-up to this study might identify 
to what degree misusers actually have untreated ADHD by having misusers undergo a formal 
clinical assessment for ADHD. It is especially important to use a formal clinical assessment for 
ADHD because this is what the ADHD symptomatology latent variable was meant to represent 
in the current study. As the CFA showed poor factor loadings on this latent variable, it may be 
best if future studies use a formal clinical assessment rather than latent variable analysis to study 
the effects of ADHD on stimulant misuse. 
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It was also hypothesized that a misuser might already be impulsively turning to substance 
abuse and experiencing associated problems from it, perhaps revealing the misuser’s attempt to 
justify another form of substance abuse to help solve academic difficulties. However, this 
hypothesis was not supported by this study’s data. Possible explanations for the failure of this 
hypothesis to be borne out by the data include, first, that there were problems discovered with the 
reliability of the substance abuse measure. However, this does not likely represent a problem 
with the DAST-10, which has been found to be a highly valid and reliable measure in past 
research (Yudko et al., 2007). Second, this study may have been underpowered for detecting the 
hypothesis, a notion discussed below in greater detail. Third, independent substance abuse 
problems may simply have little predictive value on frequency of misuse. While prior studies 
using the DAST-10 found that the majority of ADHD stimulant misusers reported significant 
substance abuse associated problems (McCabe & Teter, 2007; Sepúlveda et al., 2011), these 
studies did not use predictive models in their research design. Thus, a question has been raised 
regarding which behavior, stimulant misuse or substance abuse problems, preceded the other 
(Sepúlveda et al., 2011). A study conducted by Arria et al. (2012) found that a positive 
assessment of either cannabis use disorder or alcohol use disorder did significantly predict 
ADHD stimulant misuse. Since problems associated with substance abuse are likely to occur 
after the development of a substance use disorder, ADHD stimulant misuse may precede 
substance abuse problems. Thus, in theory, a student who is using other mind altering substances 
such as alcohol or cannabis and is experiencing academic difficulties due to unexplained 
problems with attention and impulsivity may turn to another substance, an ADHD stimulant, for 
solutions. In the long term, this form of polysubstance use may lead to medical, social, and 
family problems. Future studies could develop a predictive model that tests this hypothesis. 
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Future studies could also examine other factors that may predict frequency of misuse. 
Since the effect sizes found in this current study were relatively small, there are several apt to be 
other variables not examined here that could also contribute to a student’s desire to misuse 
ADHD stimulants. For example, this study identified age as a variable that showed a trend in this 
regard, such that older students tended to misuse ADHD stimulants more often. Other factors 
that are known correlates with both ADHD and substance abuse, such as antisocial behavior 
(Mannuzza, Klein, & Moulton, 2008; Van Eck, Markle, & Flory, 2012) and low 
conscientiousness (Lackner, Unterrainer, & Neubauer, 2013; Nigg et al., 2002), may also play 
mediating roles in the relationship between ADHD symptomatology and frequency of misuse. 
Future studies might investigate such potential intervening motives as misusers’ disinclination to 
seek medical treatment for possible ADHD symptoms as predictors of misuse among students 
with both attention and academic difficulties. 
Several other inferences and future research ideas can be drawn from the misuser and 
non-misuser characteristics. Data from the non-misusers show that ADHD stimulant misuse is 
well-known to many students and relatively common on undergraduate campuses. Thus, there is 
a need to develop targeted interventions that address reasons and preventative strategies for 
stimulant misuse, particularly for the misusers who are using stimulants without a prescription. 
Under the CSA, this is considered an illicit act (Lakhan & Kirchgessner, 2012). Additionally, 
ADHD stimulants may cause detrimental cardiovascular side-effects and at particularly high 
dose levels have addictive potential (PDR, 2017). Therefore, finding alternative methods for 
addressing academic difficulties in these students, perhaps with new study techniques or 
assessments by medical professionals to obtain stimulants in a controlled manner, is crucial. 
Another finding of interest from this study was that misusers most often took the stimulants on 
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Monday mornings. Given findings here and previously that academic reasons motivates ADHD 
stimulant misuse (Hartung et al., 2013; Peterkin et al., 2011; Rabiner et al., 2009; Teter et al., 
2005), Monday mornings may represent important or key times for optimal academic 
performance. Future studies could further investigate when and why ADHD stimulants are 
misused in order to reach these students with alternatives to misuse. Finally, misusers reported 
slight grade improvement from misuse, in agreement with previous work (Peterkin et al., 2011). 
However, there has still been no study of the precise effects ADHD stimulant misuse has on 
grades. Research models tested by Arria and colleagues (2012) did include GPA changes in data 
gathered, but these data were used to predict incidents of ADHD stimulant misuse. Studying 
objective (rather than self-report) effects of ADHD stimulant misuse on grades is an important 
area of inquiry because ADHD stimulants seem to produce cognitive benefits for those with and 
without an ADHD diagnosis (Barkley, 2014; Lakhan & Kirchgessner, 2012). 
LIMITATIONS 
 One of the more pressing limitations of this study is that it might be underpowered for 
detecting some hypotheses. As previously discussed, power analysis and sample size 
determination for SEM studies can use a variety of methods that generate different results under 
similar parameters (MacCallum et al., 1996; Muthén & Muthén, 2002; Satorra & Saris, 1985). 
This study adapted guidelines described by Wolf et al. (2013) to determine a needed sample size 
of 90 misusers. However, Fritz and MacKinnon (2007) described a post-hoc power analysis 
technique to assess if adequate power was achieved in mediation models. Using their approach, 
this study required a very broad range of 78 to 558 misusers to achieve adequate power. While 
the current study’s sample size fits within the lower end of that range, the extent of the range 
suggests that the sample size may have been problematic. To make this analysis still more 
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uncertain, Loeys, Moerkerke, and Vansteelandt (2014) argue that in studies that test for indirect 
effects, such as the current study, the Fritz and MacKinnon (2007) method may not always be 
reliable. Nevertheless, power may have been a concern that should be addressed by future 
research with larger samples of misusers to avoid weak statistical power and both falsely 
significant and falsely non-significant results (Maxwell, 2004). 
 A second limitation of the current study is the low internal consistency found for the 
DAST-10. While the notion that Cronbach’s alpha must be greater than .7 to be considered 
reliable has been refuted (Lance, Butts, & Michels, 2006), the internal consistency found in this 
study was noticeably lower than those in previous studies that utilized the DAST-10 (McCabe & 
Teter, 2007; Yudko et al., 2007). Again, the most likely explanation is that the current study was 
underpowered. However, it should also be noted that the DAST-10 has never been validated 
within a population of ADHD stimulant misusers. Should adequately-powered follow-up studies 
also experience internal consistency problems with the DAST-10, it may mean that the 
constructs represented by this measure are not prevalent among ADHD stimulant misusers. This 
would mean that studies would be needed to verify that substance abuse problems as measured 
by the DAST-10 are experienced by ADHD stimulant misusers similarly to other forms of 
substance abuse. 
 A final noteworthy limitation of this study was the method for determining frequency of 
misuse. In the survey, participants were given a blank space to freely input how often they 
misused ADHD stimulants over the past six months. Unfortunately, many participants gave 
uninterpretable answers, such that data for this variable was considered “missing” for many 
participants. While this problem was corrected for by ML estimation, the study’s findings would 
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be significantly more accurate if participants had been prompted to enter a single number to 
describe their frequency of misuse. 
CONCLUSIONS 
 In this study, ADHD symptomatology did seem to predict frequency of ADHD stimulant 
misuse and, as predicted, this effect was mediated by academic motives for misuse. Thus, 
undergraduate students experiencing dual problems with inattention/hyperactivity and academic 
difficulties might turn to ADHD stimulant misuse as a solution. As ADHD stimulant misuse is 
considered an illicit behavior, has associated health problems, and its effects on academic 
performance are not currently well understood, this may be a poor solution. Though previous 
research clearly shows that substance abuse plays a role in ADHD stimulant misuse, problems 
associated with substance abuse may occur in response to stimulant misuse alongside other 
forms of substance abuse. Age and other variables not analyzed in this study may also play 
mediating roles in ADHD stimulant misuse. Follow-up studies are crucial to continued efforts to 
delineate the motives and outcomes of what appears to be common and well-known ADHD 
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During the past 6 months, which one of the following ADHD stimulant medications have you 
used the most frequently without having a prescription for it or in a manner not recommended by 







 Other ____________________ 
 
What is the dosage of the medication indicated above that you most often use? If you do not 
know, please write "don't know" 
(Open ended response) 
 
What time of day during the past 6 months do you typically use ADHD stimulant medications 
without having a prescription for it or in a manner not recommended by the prescription's 





Which day of the week during the past 6 months do you typically use ADHD stimulant 
medications without having a prescription for it or in a manner not recommended by the 










During the past 6 months, approximately how many times have you used any ADHD stimulant 
medication without having a prescription for it or in a manner not recommended by the 
prescription's instructions (ex: taking more pills than suggested, taking pills at times not 
suggested)? 




During the past 6 months, how has taking ADHD stimulant medications (ex: Ritalin, Adderall, 
Concerta, Focalin, Vyvanse) without having a prescription for that medication or in a manner not 
recommended by the prescription's instructions (ex: taking more pills than suggested, taking pills 
at times not suggested) affected your grades? 
 Significantly decreased 
 Decreased 
 Neither decreased nor increased 
 Increased 
























In undergraduate colleges across the United States, it has been reported that some students use 
ADHD stimulant medications without having a prescription for them or in a manner not 
recommended by the prescription instructions. 
 




Do you personally know anyone who has engaged in this activity? 
 Yes 
 No 
 Don't know 
 
Do you personally know anyone who has distributed their prescription ADHD stimulant 
medication to other students who do not have a prescription for them? 
 Yes 
 No 
 Don't know 
 
Please list any drug, medication, or substance you have used in the past 6 months for the purpose 
of academic improvement. If you have not used any, please write "N/A" 













ADULT ADHD SELF-REPORT SCALE 
Please answer the questions below, rating yourself on each of the criteria shown using the 
provided scale. As you answer each question, select the response that best describes how 
you have felt and conducted yourself over the past 6 months. 
 
1. How often do you have trouble wrapping up the final details of a project, once the challenging 
parts have been done? 
 1. Never 
 2. Rarely 
 3. Sometimes 
 4. Often 
 5. Very Often 
 
2. How often do you have difficulty getting things in order when you have to do a task that 
requires organization? 
 1. Never 
 2. Rarely 
 3. Sometimes 
 4. Often 
 5. Very Often 
 
3. How often do you have problems remembering appointments or obligations? 
 1. Never 
 2. Rarely 
 3. Sometimes 
 4. Often 
 5. Very Often 
 
4. When you have a task that requires a lot of thought, how often do you avoid or delay getting 
started? 
 1. Never 
 2. Rarely 
 3. Sometimes 
 4. Often 
 5. Very Often 
 
5. How often do you fidget or squirm with your hands or feet when you have to sit down for a 
long time? 
 1. Never 
 2. Rarely 
 3. Sometimes 
 4. Often 




6. How often do you feel overly active and compelled to do things, like you were driven by a 
motor? 
 1. Never 
 2. Rarely 
 3. Sometimes 
 4. Often 
























WENDER-UTAH RATING SCALE 
 
As a child, I was (or had): 
 
1. Concentration problems, easily distracted 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
2. Anxious, worrying 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
3. Nervous, fidgety 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
4. Inattentive, daydreaming 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
5. Hot- or short-tempered, low boiling point 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
6. Temper outbursts, tantrums 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
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 5. Very much 
 
7. Trouble with stick-to-it-tiveness, not following through, failing to finish things started 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
8. Stubborn, strong-willed 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
9. Sad or blue, depressed, unhappy 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
10. Disobedient with parents, rebellious, sassy 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
11. Low opinion of myself 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
12. Irritable 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
13. Moody, ups and downs 
 1. Not at all 
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 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
14. Angry 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
15. Acting without thinking, impulsive 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
16. Tendency to be immature 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
17. Guilty feelings, regretful 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
18. Losing control of myself 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
19. Tendency to be or act irrational 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 




20. Unpopular with other children, didn’t keep friends for long, didn’t get along with other 
children 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
21. Trouble seeing things from someone else’s point of view 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
22. Trouble with authorities, troubles with school, visits to principal’s office 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
23. Overall a poor student, slow learner 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
24. Trouble with mathematics or numbers 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 
 5. Very much 
 
25. Not achieving up to potential 
 1. Not at all 
 2. Mildly 
 3. Moderately 
 4. Quite a bit 







CAFFEINE MOTIVES QUESTIONNAIRE, COGNITIVE ENHANCEMENT 
 
I choose to take ADHD stimulant medication (ex: Ritalin, Adderall, Concerta, Focalin, 
Vyvanse) without having a prescription for that medication or in a manner not 
recommended by the prescription's instructions… 
 
1. To feel more alert 
 1. Never 
 2. Rarely 
 3. Sometimes 
 4. Often 
 5. Almost always 
 
2. To help me concentrate 
 1. Never 
 2. Rarely 
 3. Sometimes 
 4. Often 
 5. Almost always 
 
3. To combat drowsiness 
 1. Never 
 2. Rarely 
 3. Sometimes 
 4. Often 
 5. Almost always 
 
4. To help me focus my attention 
 1. Never 
 2. Rarely 
 3. Sometimes 
 4. Often 
 5. Almost always 
 
5. Because I like the “jolt” of energy rush I feel 
 1. Never 
 2. Rarely 
 3. Sometimes 
 4. Often 
 5. Almost always 
 
6. To stay awake 
 1. Never 
 2. Rarely 
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 3. Sometimes 
 4. Often 



























DRUG ABUSE SCREENING TEST, 10-ITEM VERSION 
 
Answer the following questions regarding your behavior over the past 6 months excluding 
any use of ADHD stimulants (ex: Ritalin, Adderall, Concerta, Focalin, Vyvanse) 
 
1. Have you used drugs other than those required for medical reasons? 
 1. Yes 
 2. No 
 
2. Do you abuse more than one drug at a time? 
 1. Yes 
 2. No 
 
3. Are you always able to stop using drugs when you want to? (If never used drugs, answer Yes) 
 1. Yes 
 2. No 
 
4. Have you had "blackouts" or "flashbacks" as a result of drug use? 
 1. Yes 
 2. No 
 
5. Do you ever feel bad or guilty about your drug use? (If never used drugs, answer No) 
 1. Yes 
 2. No 
 
6. Does your spouse or parents ever complain about your involvement with drugs? 
 1. Yes 
 2. No 
 
7. Have you neglected your family because of your use of drugs? 
 1. Yes 
 2. No 
 
8. Have you engaged in illegal activities in order to obtain drugs? 
 1. Yes 
 2. No 
 
9. Have you ever experienced withdrawal symptoms (felt sick) when you stopped taking drugs? 
 1. Yes 
 2. No 
 
10. Have you had medical problems as a result of your drug use (e.g., memory loss, hepatitis, 
convulsions, bleeding, etc.)? 
 1. Yes 





UNIVERSITY ANNOUNCEMENT WEBPAGE 
 
Online Survey “ADHD Stimulant Usage”- Win a $50 Amazon Gift Card! 
 
Are you interested in winning a free $50 Amazon gift card? Then come participate in a study 
investigating undergraduate ADHD stimulant medication usage! The survey will take no more 
than 15 minutes to complete. All undergraduates over the age of 18 are invited to participate. 
Upon completion of the survey, you will be entered into a raffle to win a $50 Amazon gift card. 



























PROJECT TITLE: ADHD Stimulant Usage 
 
INTRODUCTION 
The purpose of this form is to give you information that may affect your decision whether to say 
YES or NO to participation in this research, and to record the consent of those who say YES. 
 
RESEARCHERS 
Alex Peterkin, Old Dominion University, Psychology Department 
Val Derlega, PhD, Old Dominion University, Psychology Department 
 
DESCRIPTION OF RESEARCH STUDY 
This research investigates undergraduate students' use of ADHD stimulant medications, 
including the use of such medications without a prescription or in a manner not recommended by 
the prescription's instructions. 
 
EXCLUSIONARY CRITERIA 
To be eligible for this study you must be at least 18 years of age or older and an undergraduate 
student at Old Dominion University 
 
RISKS AND BENEFITS  
RISKS: Participants are asked to report potentially sensitive information regarding their 
substance-use behaviors; this may cause some psychological discomfort. You are free to leave 
any question blank that you do not feel comfortable answering.     
 
BENEFITS: There are no direct benefits to participating in this study.     
 
COSTS AND PAYMENTS 
There are no costs to participate in this study. If you decide to participate in this study, you will 
be entered into a raffle for a $50 Amazon gift card.   
 
NEW INFORMATION  
If the researchers find new information during this study that would reasonably change your 
decision about participating, then they will make this available to you.     
 
CONFIDENTIALITY  
All information obtained about you in this study is strictly confidential unless disclosure is 
required by law. The researchers will take reasonable steps to keep private information, such as 
surveys and demographic data, confidential. The results of this study may be used in reports, 





It is OK for you to say NO. Even if you say YES now, you are free to say NO later, and walk 
away or withdraw from the study at any time. Your decision will not affect your relationship 
with Old Dominion University, or otherwise cause a loss of benefits to which you might 
otherwise be entitled. The researchers reserve the right to withdraw your participation in this 
study, at any time, if they observe potential problems with your continued participation. 
 
VOLUNTARY PARTICIPATION 
By participating in this research study, you are saying several things. You are saying that you 
have read this form or have had it read to you, that you are satisfied, and you understand this 
form, the research study, and its risks and benefits. If you have any questions later on, please 
contact the researcher: 
Alex Peterkin at apete047@odu.edu 
Val Derlega at vderlega@odu.edu  
 


























In the study you just participated in, we were interested in information regarding undergraduate 
ADHD stimulant misuse. This is the use of ADHD stimulants by someone who either doesn't 
have a prescription for that medication or who does have a prescription, but uses the medication 
in a manner not recommended by the prescription's instructions. 
 
If you would like to make any comments regarding this study or provide feedback that may 









SUBSTANCE ABUSE RESOURCES 
ADHD stimulant misuse is thought to be a method used by students to improve academic 
performance and does not seem to be associated with short- or long-term consequences of 
addiction and dependency. Despite this, the use of stimulant medications without a prescription 
or in a manner that deviates from the prescription's instructions is considered illegal drug use by 
the Controlled Substances Act (CSA) and may have some potentially serious health 
consequences. 
 
If you or anyone you know would like to seek help for substance abuse problems, please contact 
any of the following resources: 
 
ODU Counseling and Human Services 
110 Education Building 
Norfolk, VA, 23529 
757-683-3326 
 
Real Solutions of Virginia 
5900 East Virginia Blvd 
Janaf Office Building, Suite 101 
Norfolk, VA, 23502 
757-351-0693 
 
The Counseling Center 
400 North Center Dr 
Building 3, Suite 202 







Additionally, we and many other researchers believe that ADHD stimulant misuse may be a 
form of self-treatment for undiagnosed ADHD. If you feel that you may be suffering from 
problems with inattention, hyperactivity, distractibility, or impulsivity that is interfering your 
daily functioning, social interactions, or school or job performance, please discuss this with your 
primary care physician or contact ODU Student Health Services at 757-683-3132. 
 
 
THANK YOU FOR YOUR PARTICIPATION AND COMPLETION OF THE SURVEY! 
REMEMBER THAT THERE IS NO WAY TO LINK THE ANSWERS YOU GAVE HERE TO 
YOUR NAME OR ANY OTHER IDENTIFIERS. IF YOU HAVE ANY QUESTIONS 
REGARDING THE STUDY, PLEASE CONTACT ALEX PETERKIN AT 
APETE047@ODU.EDU OR VAL VERLEGA AT VDERLEGA@ODU.EDU. PLEASE 
CONTINUE TO THE NEXT PAGE AND YOU WILL BE REDIRECTED TO THE RAFFLE 




















Alexander Laszlo Peterkin 
Old Dominion University 
Department of Psychology 
340 Mills Godwin Building 
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